open access
Rare clinical problem — isolated ACTH deficiency associated with chronic alcohol abuse
, 3, 3, 12
Affiliations- Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
- Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital — Research Institute, Lodz, Poland
- Students’ Research Group, Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
open access
Abstract
Isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) is a rare pituitary disorder characterized by decreased secretion of ACTH, leading to cortisol deficiency, with normal secretion of other pituitary hormones. Diagnostics remains a challenge due to variable and nonspecific clinical presentation: weakness, weight loss, and low blood pressure.
Hyponatremia and anemia are typical abnormalities in basic laboratory tests. Diagnostic procedures for IAD are based on results of low morning cortisol with low/normal ACTH concentrations, with flat response of these hormones in dynamic tests [with insulin/glucagon/corticotropin-releasing hormone (CRH)]. There is also no cortisol response to Synacthen during the standard (not extended) test duration. Several aetiologies lead to the development of IAD. The congenital form is typical of childhood onset. In adults, autoimmune aetiology prevails, including lymphocytic hypophysitis, and rarer — pituitary injury or other lesions in the gland. IAD has recently been demonstrated as a complication in patients receiving therapy with immune checkpoint inhibitors.
Also, in the case of IAD, paraneoplastic autoimmune hypophysitis should be considered. Next, alcohol abuse has been reported to be a reason of IAD in single cases. Treatment with oral hydrocortisone usually causes significant improvement. As an example, we present 2 patients diagnosed with IAD. Both were older males, with history of alcohol abuse, long lasting hyponatremia, and weakness. Their clinical state normalized after receiving replacement therapy with hydrocortisone.
Abstract
Isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) is a rare pituitary disorder characterized by decreased secretion of ACTH, leading to cortisol deficiency, with normal secretion of other pituitary hormones. Diagnostics remains a challenge due to variable and nonspecific clinical presentation: weakness, weight loss, and low blood pressure.
Hyponatremia and anemia are typical abnormalities in basic laboratory tests. Diagnostic procedures for IAD are based on results of low morning cortisol with low/normal ACTH concentrations, with flat response of these hormones in dynamic tests [with insulin/glucagon/corticotropin-releasing hormone (CRH)]. There is also no cortisol response to Synacthen during the standard (not extended) test duration. Several aetiologies lead to the development of IAD. The congenital form is typical of childhood onset. In adults, autoimmune aetiology prevails, including lymphocytic hypophysitis, and rarer — pituitary injury or other lesions in the gland. IAD has recently been demonstrated as a complication in patients receiving therapy with immune checkpoint inhibitors.
Also, in the case of IAD, paraneoplastic autoimmune hypophysitis should be considered. Next, alcohol abuse has been reported to be a reason of IAD in single cases. Treatment with oral hydrocortisone usually causes significant improvement. As an example, we present 2 patients diagnosed with IAD. Both were older males, with history of alcohol abuse, long lasting hyponatremia, and weakness. Their clinical state normalized after receiving replacement therapy with hydrocortisone.
Keywords
isolated ACTH deficiency; alcohol abuse; secondary adrenal failure; hyponatremia
About this articleTitle
Rare clinical problem — isolated ACTH deficiency associated with chronic alcohol abuse
Journal
Issue
Article type
Review paper
Pages
778-783
Published online
2022-08-02
Page views
4116
Article views/downloads
839
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(4):778-783.
Keywords
isolated ACTH deficiency
alcohol abuse
secondary adrenal failure
hyponatremia
Authors
Elżbieta Skowrońska-Jóźwiak
Szymon Orzechowski
Wojciech Piętak
Andrzej Lewiński
References (22)- Orme SM, Belchetz PE. Isolated ACTH deficiency. Clin Endocrinol (Oxf). 1991; 35(3): 213–217.
- Andrioli M, Pecori Giraldi F, Cavagnini F. Isolated corticotrophin deficiency. Pituitary. 2006; 9(4): 289–295.
- Grossman A. The Diagnosis and Management of Central Hypoadrenalism. J Clin Endocrinol Metab. 2010; 95(11): 4855–4863.
- Diederich S, Franzen NF, Bähr V, et al. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003; 148(6): 609–617.
- Raff H. Glucocorticoid inhibition of neurohypophysial vasopressin secretion. Am J Physiol. 1987; 252(4 Pt 2): R635–R644.
- Kardelen Al AD, Poyrazoğlu Ş, Aslanger A, et al. A Rare Cause of Adrenal Insufficiency - Isolated ACTH Deficiency Due to TBX19 Mutation: Long-Term Follow-Up of Two Cases and Review of the Literature. Horm Res Paediatr. 2019; 92(6): 395–403.
- Kasperlik-Załuska AA, Czarnocka B, Czech W. Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases. Autoimmunity. 2003; 36(3): 155–159.
- Fujita Y, Bando H, Iguchi G, et al. Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency. Front Endocrinol (Lausanne). 2021; 12: 578802.
- Bando H, Iguchi G, Kanie K, et al. Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome. Pituitary. 2018; 21(5): 480–489.
- Iglesias P, Peiró I, Biagetti B, et al. Immunotherapy-induced isolated ACTH deficiency in cancer therapy. Endocr Relat Cancer. 2021; 28(12): 783–792.
- Gulcan E, Gulcan A, Taser F, et al. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature. Neuro Endocrinol Lett. 2007; 28(6): 745–748.
- Lewandowski KC, Malicka K, Dąbrowska K, et al. Addison's disease concomitant with corticotropin deficiency and pituitary CRH resistance - a case report. Endokrynol Pol. 2017; 68(4): 468–471.
- Baba S, Takase S, Uenoyama R, et al. Isolated corticotrophin-deficiency found through alcohol-induced hypoglycemic coma. Horm Metab Res. 1976; 8(4): 274–278.
- Kearney T, Robinson S, Johnston DG. Isolated corticotropin deficiency in chronic alcoholism. J R Soc Med. 2000; 93(1): 15–17.
- Steer P, Marnell R, Werk EE. Clinical alcohol hypoglycemia and isolated adrenocorticotrophic hormone deficiency. Ann Intern Med. 1969; 71(2): 343–348.
- Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(11): 3888–3921.
- Iwama S, Arima H. Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands. Endocr J. 2020; 67(11): 1077–1083.
- Marks V. Alcohol and changes in body constitutent; glucose and hormones. Proc R Soc Med. 1975; 68(6): 377–380.
- Scaroni C, Albiger NM, Palmieri S, et al. Altogether to Beat Cushing’s Syndrome (ABC) study group. Approach to patients with pseudo-Cushing's states. Endocr Connect. 2020; 9(1): R1–R13.
- Mick I, Spring K, Uhr M, et al. Alcohol administration attenuates hypothalamic-pituitary-adrenal (HPA) activity in healthy men at low genetic risk for alcoholism, but not in high-risk subjects. Addict Biol. 2013; 18(5): 863–871.
- Curley DE, Webb AE, Sheffler DJ, et al. Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research. Front Behav Neurosci. 2021; 15: 786855.
- Richtsmeier A. Lymphoid Hypophysitis With Selective Adrenocorticotropic Hormone Deficiency. Arch Int Med. 1980; 140(9): 1243–1245.
